Charles B. Wright

964 total citations
18 papers, 355 citations indexed

About

Charles B. Wright is a scholar working on Molecular Biology, Ophthalmology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Charles B. Wright has authored 18 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Ophthalmology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Charles B. Wright's work include Retinal Development and Disorders (8 papers), Retinal Diseases and Treatments (6 papers) and RNA regulation and disease (2 papers). Charles B. Wright is often cited by papers focused on Retinal Development and Disorders (8 papers), Retinal Diseases and Treatments (6 papers) and RNA regulation and disease (2 papers). Charles B. Wright collaborates with scholars based in United States, France and Italy. Charles B. Wright's co-authors include Jayakrishna Ambati, John M. Nickerson, T. Michael Redmond, Nathan L. Vanderford, Reo Yasuma, Tetsuhiro Yasuma, Ana Bastos-Carvalho, Shengjian Li, Bradley D. Gelfand and Benjamin J. Fowler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Biotechnology.

In The Last Decade

Charles B. Wright

17 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles B. Wright United States 10 218 137 55 33 29 18 355
Asfa Alli‐Shaik Singapore 10 153 0.7× 40 0.3× 54 1.0× 20 0.6× 21 0.7× 16 332
Jason Mighty United States 11 221 1.0× 37 0.3× 32 0.6× 49 1.5× 13 0.4× 13 305
Arno Hueber Germany 12 158 0.7× 294 2.1× 218 4.0× 22 0.7× 10 0.3× 25 447
Andreas Rentsch Germany 11 274 1.3× 74 0.5× 9 0.2× 17 0.5× 11 0.4× 19 375
A Kanai Japan 15 224 1.0× 244 1.8× 328 6.0× 9 0.3× 23 0.8× 55 664
Kalyan Dulla Netherlands 11 427 2.0× 66 0.5× 65 1.2× 23 0.7× 18 0.6× 16 519
Eva Kniep Germany 10 122 0.6× 26 0.2× 39 0.7× 131 4.0× 25 0.9× 13 334
Jianan Xie China 12 200 0.9× 92 0.7× 80 1.5× 19 0.6× 22 0.8× 26 331
Sujay Shah United States 7 171 0.8× 10 0.1× 13 0.2× 14 0.4× 12 0.4× 11 311

Countries citing papers authored by Charles B. Wright

Since Specialization
Citations

This map shows the geographic impact of Charles B. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles B. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles B. Wright more than expected).

Fields of papers citing papers by Charles B. Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles B. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles B. Wright. The network helps show where Charles B. Wright may publish in the future.

Co-authorship network of co-authors of Charles B. Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Charles B. Wright. A scholar is included among the top collaborators of Charles B. Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles B. Wright. Charles B. Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Becker, Steven M. & Charles B. Wright. (2020). Update on the Status and Impact of the National Eye Institute Audacious Goals Initiative for Regenerative Medicine. Journal of Ocular Pharmacology and Therapeutics. 37(3). 144–146. 2 indexed citations
2.
Wright, Charles B., et al.. (2020). NEI-Supported Age-Related Macular Degeneration Research: Past, Present, and Future. Translational Vision Science & Technology. 9(7). 49–49. 6 indexed citations
3.
Wright, Charles B., Steven M. Becker, Lucie A. Low, Danilo A. Tagle, & Paul A. Sieving. (2019). Improved Ocular Tissue Models and Eye-On-A-Chip Technologies Will Facilitate Ophthalmic Drug Development. Journal of Ocular Pharmacology and Therapeutics. 36(1). 25–29. 10 indexed citations
4.
Wright, Charles B., et al.. (2018). Diversity in the Vision Research Community. Investigative Ophthalmology & Visual Science. 59(9). 6169–6169. 1 indexed citations
5.
Foster, Stephanie L., Micah A. Chrenek, Jana T Sellers, et al.. (2018). Xanthohumol Protects Morphology and Function in a Mouse Model of Retinal Degeneration. Investigative Ophthalmology & Visual Science. 59(1). 45–45. 2 indexed citations
6.
Wright, Charles B. & Nathan L. Vanderford. (2017). What faculty hiring committees want. Nature Biotechnology. 35(9). 885–887. 21 indexed citations
7.
Wright, Charles B. & Nathan L. Vanderford. (2017). Closing Kynect and Restructuring Medicaid Threaten Kentucky's Health and Economy. Journal of Health Politics Policy and Law. 42(4). 719–737. 1 indexed citations
8.
Wright, Charles B. & Jayakrishna Ambati. (2016). Dry Age-Related Macular Degeneration Pharmacology. Handbook of experimental pharmacology. 321–336. 20 indexed citations
9.
Gelfand, Bradley D., Charles B. Wright, Young‐Hee Kim, et al.. (2015). Iron Toxicity in the Retina Requires Alu RNA and the NLRP3 Inflammasome. Cell Reports. 11(11). 1686–1693. 70 indexed citations
10.
Wright, Charles B., T. Michael Redmond, & John M. Nickerson. (2015). A History of the Classical Visual Cycle. Progress in molecular biology and translational science. 134. 433–448. 36 indexed citations
11.
Wright, Charles B., Young‐Hee Kim, Tetsuhiro Yasuma, et al.. (2014). Enhanced Alu RNA stability due to iron-mediated DICER1 impairment causes NLRP3 inflammasome priming. Investigative Ophthalmology & Visual Science. 55(13). 2187–2187. 1 indexed citations
12.
Kim, Younghee, Valeria Tarallo, Nagaraj Kerur, et al.. (2014). DICER1/ Alu RNA dysmetabolism induces Caspase-8–mediated cell death in age-related macular degeneration. Proceedings of the National Academy of Sciences. 111(45). 16082–16087. 74 indexed citations
13.
Wright, Charles B., Micah A. Chrenek, Wei Feng, et al.. (2014). TheRpe65rd12Allele Exerts a Semidominant Negative Effect on Vision in Mice. Investigative Ophthalmology & Visual Science. 55(4). 2500–2500. 13 indexed citations
14.
Wright, Charles B., Micah A. Chrenek, Stephanie L. Foster, et al.. (2013). Complementation Test ofRpe65Knockout and Tvrm148. Investigative Ophthalmology & Visual Science. 54(7). 5111–5111. 9 indexed citations
15.
Chrenek, Micah A., et al.. (2010). Non-contact measurement of linear external dimensions of the mouse eye. Journal of Neuroscience Methods. 187(2). 156–166. 17 indexed citations
16.
Lee, Hyun‐Wook, et al.. (2010). Identification of Escherichia coli Mismatch-specific Uracil DNA Glycosylase as a Robust Xanthine DNA Glycosylase. Journal of Biological Chemistry. 285(53). 41483–41490. 16 indexed citations
17.
Wempe, Michael F., Charles B. Wright, James L. Little, et al.. (2008). Inhibiting efflux with novel non-ionic surfactants: Rational design based on vitamin E TPGS. International Journal of Pharmaceutics. 370(1-2). 93–102. 56 indexed citations
18.
Wright, Charles B.. (1982). Professor Josef Lederer. Some Notes on His Career. Clinical and Experimental Optometry. 65(2). 52–55.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026